[ORGANIZATION]
Multicare Pharmaceuticals
Featured in 1 tracked story · first seen
Situations
Duchenne muscular dystrophy drug regulation in Brazil
2 clusters · 28 sources · last updated
Latest: Anvisa and Roche cancel Elevidys registration in Brazil
In August 2026, Brazil’s National Health Surveillance Agency (Anvisa) issued two significant regulatory decisions regarding treatments for Duchenne muscular dystrophy (DMD). First, Anvisa approved the registration of Du